👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'

Published 05/12/2023, 14:25
Updated 05/12/2023, 15:40
© Reuters.  Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'
MS
-
CVS
-

Benzinga - by Lisa Levin, Benzinga Editor.

On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said he is staying with U.S. 1 Year Treasury Bill, which has over 5% yield.

Jim Lebenthal of Cerity Partners picked CVS Health Corporation (NYSE: CVS), which is scheduled to hold Investor Day on Dec. 5, 2023.

On Nov. 1, CVS Health said third-quarter sales increased 10.6% Y/Y to $89.76 billion, beating the consensus of $88.25 billion.

Don’t forget to check out our premarket coverage here

Sarat Sethi named Morgan Stanley (NYSE: MS) as his final trade amid a pickup in market activity.

Morgan Stanley appointed its co-president, Edward (Ted) Pick, as chief executive officer, effective Jan. 1.

Liz Young of BNY Mellon Investment Management picked Invesco Food & Beverage ETF (NYSE: PBJ).

Price Action: CVS Health shares closed at $68.48 on Monday, while Morgan Stanley gained 0.4% to $81.21. Invesco Food & Beverage ETF gained 0.7% during Monday’s session.

Check This Out: How To Earn $500 A Month From Dell Stock Following Last Week's Upbeat Earnings

Image: Pixabay

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.